Observational studyJournal of diabetes investigation2026
Outcomes of insulin treatment using an automated insulin delivery system from the onset of type 1 diabetes in pediatric patients-A 1-year retrospective, observational, two-center study.
Observational study in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMiniMed 780G was the first automated insulin delivery (AID) system approved in Poland. Although it has been studied extensively, there are relatively less data regarding its use in children with type 1 diabetes from the onset of the disease. We aimed to evaluate and compare glycemic parameters in children treated from type 1 diabetes onset with either an AID system or a pump with predictive-low glucose suspend (SAP-PLGS). MATERIAL AND
methodsWe retrospectively gathered anthropometric data and systems records of 50 children with a newly diagnosed type 1 diabetes, 22 using an AID system (aged 9.66 ± 3.76 years), and 28 using a SAP-PLGS device (aged 8.13 ± 4.2 years). Glycemic parameters and other collected data were compared at four different time points: the first 2 weeks using the insulin pump and 2 weeks after 3, 6, and 12 months of insulin therapy.
resultsAfter the first year of treatment, we found in the AID group higher time in range (TIR) 70-180 mg/dL (P = 0.001) as well as time in tight range (TITR) 70-140 mg/dL (P = 0.0003). There were no significant differences in the C-peptide level after 1 year of treatment between the two studied groups (P = 0.41).
conclusionsUsing the AID system from the onset of type 1 diabetes resulted in improved glycemic control parameters in the studied children compared with using SAP-PLGS. The C-peptide preservation was comparable in both analyzed groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.